KRKA tovarna zdravil d.d. Novo mesto
32 products tracked · names used in filings: KRKA tovarna zdravil d.d. Novo mesto
Upcoming milestones
Mon 18 Jan 2027🇪🇺 Expected EC decisionestimatein 65 days
Ruxolitinib Krka (ruxolitinib): expected EC decision
Estimated as CHMP opinion (2026-11-12) + 67 days, the standard Commission decision period. Not an official date. · KRKA tovarna zdravil d.d. Novo mesto · source
Recent milestones
Thu 12 Nov 2026🇪🇺 CHMP positive opinion
Ruxolitinib Krka (ruxolitinib): CHMP positive opinion
KRKA tovarna zdravil d.d. Novo mesto; Generic · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Ruxolitinib Krka ruxolitinib | Opinion | |
| 🇪🇺 | Desloratadine Krka desloratadine | Application withdrawn | |
| 🇪🇺 | Pomalidomide Krka pomalidomide | Authorised | 2024-07-24 |
| 🇪🇺 | Abiraterone Krka abiraterone acetate | Authorised | 2021-06-24 |
| 🇪🇺 | Lenalidomide Krka d.d. Novo mesto (previously Lenalidomide Krka) lenalidomide | Authorised | 2021-02-11 |
| 🇪🇺 | Lenalidomide Krka d.d. lenalidomide | Withdrawn | 2021-02-11 |
| 🇪🇺 | Lenalidomide Krka (previously Lenalidomide Krka d.d. Novo mesto) lenalidomide | Authorised | 2021-02-11 |
| 🇪🇺 | Febuxostat Krka febuxostat | Authorised | 2019-03-28 |
| 🇪🇺 | Atazanavir Krka atazanavir | Withdrawn | 2019-03-25 |
| 🇪🇺 | Pemetrexed Krka pemetrexed | Withdrawn | 2018-05-22 |
| 🇪🇺 | Efavirenz/Emtricitabine/Tenofovir disoproxil Krka efavirenz;emtricitabine;tenofovir disoproxil | Authorised | 2018-02-08 |
| 🇪🇺 | Darunavir Krka darunavir | Authorised | 2018-01-26 |
| 🇪🇺 | Darunavir Krka d.d. darunavir | Expired | 2018-01-18 |
| 🇪🇺 | Emtricitabine/Tenofovir disoproxil Krka d.d. emtricitabine;tenofovir disoproxil | Authorised | 2017-04-28 |
| 🇪🇺 | Emtricitabine/Tenofovir disoproxil Krka emtricitabine;tenofovir disoproxil | Authorised | 2016-12-09 |
| 🇪🇺 | Marixino (previously Maruxa) memantine | Authorised | 2013-04-28 |
| 🇪🇺 | Tolucombi telmisartan;hydrochlorothiazide | Authorised | 2013-03-13 |
| 🇪🇺 | Ecansya (previously Capecitabine Krka) capecitabine | Authorised | 2012-04-20 |
| 🇪🇺 | Pioglitazone Krka pioglitazone | Withdrawn | 2012-03-21 |
| 🇪🇺 | Paglitaz pioglitazone | Lapsed | 2012-03-21 |
| 🇪🇺 | Dasselta desloratadine | Authorised | 2011-11-28 |
| 🇪🇺 | Ifirmacombi irbesartan;hydrochlorothiazide | Authorised | 2011-03-04 |
| 🇪🇺 | Tolura telmisartan | Authorised | 2010-06-04 |
| 🇪🇺 | Repaglinide Krka repaglinide | Authorised | 2009-11-03 |
| 🇪🇺 | Enyglid repaglinide | Authorised | 2009-10-13 |
| 🇪🇺 | Zyllt clopidogrel | Authorised | 2009-09-28 |
| 🇪🇺 | Clopidogrel Krka clopidogrel | Authorised | 2009-09-23 |
| 🇪🇺 | Vizarsin sildenafil | Authorised | 2009-09-21 |
| 🇪🇺 | Nimvastid rivastigmine | Authorised | 2009-05-11 |
| 🇪🇺 | Ifirmasta (previously Irbesartan Krka) irbesartan | Authorised | 2008-12-01 |
| 🇪🇺 | Oprymea pramipexole | Authorised | 2008-09-12 |
| 🇪🇺 | Zalasta olanzapine | Authorised | 2007-09-27 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.